Acute Myeloid Leukemia is a complicated illness and requires a personalized approach to treatment. The graphics we designed effectively communicate the various treatment options to the patient in a clear and easy-to-understand visual format.
We created a series of visuals for a Medical Publishing - Medical Affairs client, aimed at assisting patients in comprehending the information in the booklet about their treatment plan.
Client
Medical Publishing
Medical Affairs
Project Management
René Molenaar
Illustration
Lara Laghetto
Writing
Marijke van Oosten
We took into consideration the color palette and publishing restrictions to develop the graphics, ensuring the patients have a thorough understanding of their condition.
It was essential to provide a clear and visually understandable explanation of the distinction between Autologous and Allogeneic cell therapy.
Autologous cell therapy involves harvesting the patient's own cells, modifying them, and reintroducing them back into their body. This approach completely eliminates the risk of an adverse immune response.
On the other hand, Allogeneic cell therapy utilizes cells from a healthy donor, which are then infused into individuals who need them. Although there is a small chance of an immune response in this case, it is important to note that the risk has been significantly reduced.
By presenting this information in a simple and visual manner, we can enhance understanding and facilitate informed decision-making for patients and healthcare professionals alike.
Iterations to
achieve clarity
